Angiodynamics Value Stock - Dividend - Research Selection

Angiodynamics (ISIN: US03475V1017, WKN: A0B9A5)Market price date: 21.11.2019 Market price: 15,22 USD
DescriptionData
SymbolANGO
Market Capitalization579.872.896,00 USD
CountryVereinigte Staaten von Amerika
IndicesNASDAQ Comp.
SectorGesundheitswesen
Raw Data SourceUS GAAP in Millionen USD
Stock Split
Internetwww.angiodynamics.com
Last Balance Sheet Update14.07.2019

Fundamentals

Fundamental ratios calculated on: 21-11-2019
P/FCP/CDiv. YieldROIROEP/EP/SP/B
16,9015,490,00%7,3373,509,451,610,94

Description of the company

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; Asclera drug for treating uncomplicated spider and reticular veins of the lower extremities; and Sotradecol drugs for treating small uncomplicated varicose veins of the lower extremities. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. In addition, the company provides thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. Further, it offers peripherally inserted central catheters; ports that are implantable devices for the central venous administration; and dialysis products. Additionally, the company provides microwave ablation products; radiofrequency ablation products for ablating solid cancerous or benign tumors; and NanoKnife ablation systems for the surgical ablation of soft tissues. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, and interventional and surgical oncologists directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.angiodynamics.com

Test us!